These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages]. Rüttinger H; Hermes M Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261 [No Abstract] [Full Text] [Related]
4. In vivo characterization of the multiple sclerosis plaque by magnetic resonance imaging and spectroscopy. Larsson HB Acta Neurol Scand Suppl; 1995; 159():1-44. PubMed ID: 7625161 [No Abstract] [Full Text] [Related]
6. Psychiatric symptoms and mental changes as major features of multiple sclerosis. Sanders EA; van Lieshout HB Clin Neurol Neurosurg; 1992; 94 Suppl():S144-6. PubMed ID: 1320493 [TBL] [Abstract][Full Text] [Related]
7. Serial study of neuropsychological performance and gadolinium-enhanced MRI in MS. Mattioli F; Cappa SF; Cominelli C; Capra R; Marcianoc N; Gasparotti R Acta Neurol Scand; 1993 Jun; 87(6):465-8. PubMed ID: 8356876 [TBL] [Abstract][Full Text] [Related]
12. [Intracranial tumor-like lesions in children and young adults with multiple sclerosis]. Einig M; Higer HP; Mauz M; Ernst JP Rofo; 1992 Oct; 157(4):384-9. PubMed ID: 1391842 [TBL] [Abstract][Full Text] [Related]
13. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Thompson AJ; Miller D; Youl B; MacManus D; Moore S; Kingsley D; Kendall B; Feinstein A; McDonald WI Neurology; 1992 Jan; 42(1):60-3. PubMed ID: 1734325 [TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Grossman RI; Braffman BH; Brorson JR; Goldberg HI; Silberberg DH; Gonzalez-Scarano F Radiology; 1988 Oct; 169(1):117-22. PubMed ID: 3420246 [TBL] [Abstract][Full Text] [Related]
15. [Clinical usefulness of MRI in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase]. Nomura M; Suzumura A; Anno H; Miyata E; Koga S; Yamamoto H Rinsho Shinkeigaku; 1995 Mar; 35(3):225-30. PubMed ID: 7614741 [TBL] [Abstract][Full Text] [Related]
16. ECT as a treatment for depression in Huntington's disease. Ranen NG; Peyser CE; Folstein SE J Neuropsychiatry Clin Neurosci; 1994; 6(2):154-9. PubMed ID: 8044037 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of ECT in patients with head injury: a case series. Kant R; Coffey CE; Bogyi AM J Neuropsychiatry Clin Neurosci; 1999; 11(1):32-7. PubMed ID: 9990553 [TBL] [Abstract][Full Text] [Related]
18. MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines. Paty DW; Li DK; Koopmans R J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):978. PubMed ID: 1431970 [No Abstract] [Full Text] [Related]
19. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)]. Gowin W; Weihe W; Appel C; Mariss G Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314 [No Abstract] [Full Text] [Related]
20. Treatment resistant depression in the elderly: a review of its conceptualisation, management and relationship to organic brain disease. Baldwin RC; Simpson S J Affect Disord; 1997 Dec; 46(3):163-73. PubMed ID: 9547114 [No Abstract] [Full Text] [Related] [Next] [New Search]